| Literature DB >> 32693296 |
Sylwia Sudoł1, Katarzyna Kucwaj-Brysz2, Rafał Kurczab3, Natalia Wilczyńska4, Magdalena Jastrzębska-Więsek4, Grzegorz Satała3, Gniewomir Latacz1, Monika Głuch-Lutwin5, Barbara Mordyl5, Ewa Żesławska6, Wojciech Nitek7, Anna Partyka4, Kamila Buzun8, Agata Doroz-Płonka1, Anna Wesołowska4, Anna Bielawska9, Jadwiga Handzlik10.
Abstract
In the light of recent lines of evidence, 5-HT6R ligands are a promising tool for future treatment of memory impairment. Hence, this study has supplied highly potent 5-HT6R agents with procognitive effects, which represent an original chemical class of 1,3,5-triazines, different from widely studied sulfone and indole-like 5-HT6R ligands. The new compounds were rationally designed as modifications of lead, 4-(1-(2-chlorophenoxy)ethyl)-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-amine (1), involving an introduction of: (i) two chlorines at benzene ring and (ii) varied linkers joining the triazine ring to aromatic ethers. Synthesis, in vitro and in vivo biological tests and computer-aided SAR analysis for 19 new compounds were carried out. Most of the new triazines displayed high affinity (Ki < 100 nM) and selectivity towards 5-HT6R, with respect to 5-HT2AR, 5-HT7R and D2R. The crystallography-supported docking studies, including quantum-polarized ligand docking (QPLD), indicated that chlorine atoms may be involved in different type of halogen bonding, however, the linker properties seem to predominately affect the 5-HT6R affinity. 4-[1-(2,5-Dichlorophenoxy)propyl]-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-amine (9), which displayed: the highest affinity (Ki = 6 nM), very strong 5-HT6R antagonistic action (KB = 27 pM), procognitive effects in vivo in novel object recognition (NOR) test in rats, a very good permeability in PAMPA model and satisfying safety in vitro, was identified as the most potent 1,3,5-triazine agent so far, useful as a new lead for further research.Entities:
Keywords: 1,3,5-Triazine; 5-HT(6) antagonist; Docking QPLD; Halogen bonds; Procognitive; Serotonin receptors
Mesh:
Substances:
Year: 2020 PMID: 32693296 DOI: 10.1016/j.ejmech.2020.112529
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514